What is Curve Biosciences worth?
$34.7Mlast known valuation
Curve Biosciences last raised $17.7M in its Early Stage VC (May 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Curve Biosciences
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2024 | Early Stage VC | $17.7M | ▮ | ▮ |
How Curve Biosciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Curve Biosciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Curve Biosciences worth?
- Curve Biosciences's last known valuation is $34.7M.
- How much has Curve Biosciences raised?
- Curve Biosciences has raised $56.0M in total funding across 1 recorded rounds.
- When did Curve Biosciences last raise?
- Curve Biosciences last raised in May 2024 (Early Stage VC), raising $17.7M.